MedicarePartD.guide

A non-government resource built from CMS public data

SGLT2 inhibitors on every 2026 Arizona Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Arizona cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
SGLT2 inhibitors by 2026 Arizona Part D plan
DrugWellcare Classic$0.00/moS4802-092Wellcare Value Script$0.00/moS4802-134HealthSpring Assurance Rx$0.00/moS5617-138Humana Basic Rx Plan$0.00/moS5884-146Humana Value Rx Plan$2.50/moS5884-207AARP Medicare Rx Saver from UHC$38.70/moS5921-380HealthSpring Extra Rx$66.40/moS5617-378SilverScript Choice$94.90/moS5601-056AARP Medicare Rx Preferred from UHC$97.50/moS5921-409Humana Premier Rx Plan$119.20/moS5884-174
JardianceempagliflozinTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 323%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30dTier 317%QL 30/30dTier 318%QL 30/30dTier 318%QL 30/30dTier 3$45.00QL 30/30d
FarxigadapagliflozinNot coveredNot coveredTier 325%QL 30/30dTier 323%QL 30/30dTier 320%QL 30/30dNot coveredTier 317%QL 30/30dTier 318%QL 30/30dNot coveredTier 3$45.00QL 30/30d
dapagliflozingeneric FarxigaTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 323%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30dTier 317%QL 30/30dTier 318%QL 30/30dTier 318%QL 30/30dTier 3$45.00QL 30/30d
InvokanacanagliflozinTier 432%QL 60/30dTier 440%QL 60/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
SteglatroertugliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
InpefasotagliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.